The EU is reshaping its biotechnology landscape, with the focus on competitiveness, supply and capacity resilience and societal benefit. A European Commission 5 year mandate has over 20 legislations and initiatives relevant to biotech and is an opportunity to both anchor and grow European innovation and create an attractive ecosystem for investment for global partners. Speakers from across the European Commission will address the legislations that are the cornerstone of biotechnology performance, including the EU Biotech Act, General Pharmaceutical Legislation, Critical Medicines Act and others. These legislations aim to accelerate the growth of biotech to market and are underpinned by innovative funding models for industry from institutions such as the European Innovation Council. Join the panel to find out how major legislative actions support innovation in the European Union and connect to the European Commission.